| Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer | |
| Sun, Yongkun; Du, Feng; Gao, Ming; Ji, Qinghai; Li, Zhendong; Zhang, Yuan; Guo, Zhuming; Wang, Jun; Chen, Xiangjin; Wang, Jinwan | |
| 2018 | |
| 卷号 | 28期号:11页码:1455-1461 |
| 关键词 | anlotinib medullary thyroid carcinoma clinical trial |
| ISSN号 | 1050-7256 |
| DOI | 10.1089/thy.2018.0022 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6355041 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Sun, Yongkun,Du, Feng,Gao, Ming,et al. Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer[J],2018,28(11):1455-1461. |
| APA | Sun, Yongkun.,Du, Feng.,Gao, Ming.,Ji, Qinghai.,Li, Zhendong.,...&Tang, Pingzhang.(2018).Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer.,28(11),1455-1461. |
| MLA | Sun, Yongkun,et al."Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer".28.11(2018):1455-1461. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论